Suppr超能文献

组织样本的蛋白质组学分析揭示甲状旁腺增生相对于腺瘤中线粒体蛋白水平的变化。

Proteomics Analysis of Tissue Samples Reveals Changes in Mitochondrial Protein Levels in Parathyroid Hyperplasia over Adenoma.

作者信息

Akpinar Gurler, Kasap Murat, Canturk Nuh Zafer, Zulfigarova Mehin, Islek Eylül Ece, Guler Sertac Ata, Simsek Turgay, Canturk Zeynep

机构信息

Department of Medical Biology and Genetics, School of Medicine, Kocaeli University, Kocaeli, Turkey

DEKART Proteomics Laboratory, Kocaeli University, Kocaeli, Turkey.

出版信息

Cancer Genomics Proteomics. 2017 May-Jun;14(3):197-211. doi: 10.21873/cgp.20031.

Abstract

BACKGROUND/AIM: To unveil the pathophysiology of primary hyperparathyroidism, molecular details of parathyroid hyperplasia and adenoma have to be revealed. Such details will provide the tools necessary for differentiation of these two look-alike diseases. Therefore, in the present study, a comparative proteomic study using postoperative tissue samples from the parathyroid adenoma and parathyroid hyperplasia patients was performed.

MATERIALS AND METHODS

Protein extracts were prepared from tissue samples (n=8 per group). Protein pools were created for each group and subjected to DIGE and conventional 2DE. Following image analysis, spots representing the differentially regulated proteins were excised from the and used for identification via MALDI-TOF/TOF analysis.

RESULTS

The identities of 40 differentially-expressed proteins were revealed. Fourteen of these proteins were over-expressed in the hyperplasia while 26 of them were over-expressed in the adenoma.

CONCLUSION

Most proteins found to be over-expressed in the hyperplasia samples were mitochondrial, underlying the importance of the mitochondrial activity as a potential biomarker for differentiation of parathyroid hyperplasia from adenoma.

摘要

背景/目的:为揭示原发性甲状旁腺功能亢进症的病理生理学,必须了解甲状旁腺增生和腺瘤的分子细节。这些细节将为区分这两种相似疾病提供必要的工具。因此,在本研究中,我们对甲状旁腺腺瘤和甲状旁腺增生患者的术后组织样本进行了比较蛋白质组学研究。

材料与方法

从组织样本中制备蛋白质提取物(每组n = 8)。为每组创建蛋白质池,并进行差异凝胶电泳(DIGE)和传统的二维电泳(2DE)。图像分析后,从凝胶中切下代表差异调节蛋白的斑点,并通过基质辅助激光解吸电离飞行时间串联质谱(MALDI-TOF/TOF)分析进行鉴定。

结果

揭示了40种差异表达蛋白的身份。其中14种蛋白在增生组织中过度表达,26种在腺瘤中过度表达。

结论

在增生样本中发现过度表达的大多数蛋白是线粒体蛋白,这突出了线粒体活性作为区分甲状旁腺增生和腺瘤的潜在生物标志物的重要性。

相似文献

2
The differential diagnosis of parathyroid adenoma and chief cell hyperplasia.
Am J Clin Pathol. 1968 Jun;49(6):761-75. doi: 10.1093/ajcp/49.6.761.
3
6
Molecular classification of parathyroid neoplasia by gene expression profiling.
Am J Pathol. 2004 Aug;165(2):565-76. doi: 10.1016/S0002-9440(10)63321-4.
7
Water-clear-cell hyperplasia mimicking parathyroid adenoma.
Hum Pathol. 1985 Oct;16(10):1075-6. doi: 10.1016/s0046-8177(85)80289-6.

引用本文的文献

1
Vitamin D receptor: a possible biomarker for sporadic parathyroid adenoma?
Updates Surg. 2025 Apr 5. doi: 10.1007/s13304-025-02182-5.
2
Sporadic Parathyroid Adenoma: A Pilot Study of Novel Biomarkers in Females.
Medicina (Kaunas). 2024 Jul 5;60(7):1100. doi: 10.3390/medicina60071100.
3
Protein Signatures of Parathyroid Adenoma according to Tumor Volume and Functionality.
Endocrinol Metab (Seoul). 2024 Apr;39(2):375-386. doi: 10.3803/EnM.2023.1827. Epub 2024 Mar 21.
4
Sporadic parathyroid adenoma: an updated review of molecular genetics.
Front Endocrinol (Lausanne). 2023 May 8;14:1180211. doi: 10.3389/fendo.2023.1180211. eCollection 2023.
5
Applications of MALDI-MS/MS-Based Proteomics in Biomedical Research.
Molecules. 2022 Sep 21;27(19):6196. doi: 10.3390/molecules27196196.
6
Parathyroid Carcinoma and Adenoma Co-existing in One Patient: Case Report and Comparative Proteomic Analysis.
Cancer Genomics Proteomics. 2021 Nov-Dec;18(6):781-796. doi: 10.21873/cgp.20297.
7
Disorders of Calcium and Phosphorus Metabolism and the Proteomics/Metabolomics-Based Research.
Front Cell Dev Biol. 2020 Sep 10;8:576110. doi: 10.3389/fcell.2020.576110. eCollection 2020.
10
Quantitative proteomics analysis of sporadic parathyroid adenoma tissue samples.
J Endocrinol Invest. 2019 May;42(5):577-590. doi: 10.1007/s40618-018-0958-1. Epub 2018 Oct 3.

本文引用的文献

1
2
Primary hyperparathyroidism.
Nat Rev Dis Primers. 2016 May 19;2:16033. doi: 10.1038/nrdp.2016.33.
3
Clinicopathological correlates of hyperparathyroidism.
J Clin Pathol. 2015 Oct;68(10):771-87. doi: 10.1136/jclinpath-2015-203186. Epub 2015 Jul 10.
4
Preoperative imaging for focused parathyroidectomy: making a good strategy even better.
Eur J Endocrinol. 2015 May;172(5):519-26. doi: 10.1530/EJE-14-0964. Epub 2015 Jan 30.
5
STRING v10: protein-protein interaction networks, integrated over the tree of life.
Nucleic Acids Res. 2015 Jan;43(Database issue):D447-52. doi: 10.1093/nar/gku1003. Epub 2014 Oct 28.
6
The surgical management of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop.
J Clin Endocrinol Metab. 2014 Oct;99(10):3595-606. doi: 10.1210/jc.2014-2000. Epub 2014 Aug 27.
7
Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop.
J Clin Endocrinol Metab. 2014 Oct;99(10):3561-9. doi: 10.1210/jc.2014-1413. Epub 2014 Aug 27.
8
Surgery for primary hyperparathyroidism.
Cancer. 2014 Dec 1;120(23):3602-16. doi: 10.1002/cncr.28891. Epub 2014 Jul 9.
9
Changes in parathyroid proteome in patients with primary hyperparathyroidism due to sporadic parathyroid adenomas.
Clin Endocrinol (Oxf). 2014 Oct;81(4):614-20. doi: 10.1111/cen.12479. Epub 2014 Jun 5.
10
Genetic and epigenetic changes in sporadic endocrine tumors: parathyroid tumors.
Mol Cell Endocrinol. 2014 Apr 5;386(1-2):46-54. doi: 10.1016/j.mce.2013.09.005. Epub 2013 Sep 11.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验